What Are Peptides? A Plain-Language Guide to Peptide Therapy

You've probably heard the word "peptides" everywhere lately. From your favorite health podcast to a friend who started injecting something before bed and is sleeping better than they have in years. And then you asked your regular doctor about it and got a blank stare.

That's the gap this article fills. If you've been wondering what are peptides, how they actually work in your body, and whether any of this is worth your time and money, this is the straight explanation you didn't get from your doctor.

Here's what's true: peptides are not supplements. They're not steroids. And the category is enormous, covering everything from the insulin that keeps diabetics alive to experimental compounds people are ordering online for injuries. The difference between those things matters a lot, and nobody's explaining it clearly.

We will.

---

What Are Peptides, Exactly?

Peptides are short chains of amino acids, the same building blocks that make up proteins, just in smaller sequences (Zasloff, 2002).

Here's the quick version: if amino acids are individual letters, a peptide is a short word. A protein is a whole sentence. Your body already makes tens of thousands of different peptides. Insulin is one. Oxytocin is one. The signal peptides that tell your cells to repair damaged tissue are peptides. Growth hormone is a peptide. So is glucagon.

The difference between a peptide and a full protein comes down to length. Peptides are typically 2 to 50 amino acids long. Proteins are longer chains, often hundreds or thousands of amino acids folded into complex 3D structures (Lau, 2018).

Why does the length matter? Smaller chains are easier for your body to handle, more targeted in what they do, and in some cases easier to synthesize in a lab. That's what makes them interesting as medicine.

Peptides have been used in medicine since 1922, when the first insulin was isolated and used to treat diabetes (Lau, 2018). Today, there are over 100 FDA-approved peptide drugs on the market. You probably know several of them by their brand names even if you didn't know they were peptides (Fosgerau, 2015).

---

How Do Peptides Work in the Body?

Peptides work as messengers. They bind to specific receptors on the surface of cells and trigger a biological response.

Think of it like a key-and-lock system. Each peptide is shaped to fit a specific receptor. When it binds, it tells the cell to do something: release a hormone, repair tissue, ramp up growth hormone production, regulate appetite. The response is specific to both the peptide and the receptor (Zasloff, 2002).

This specificity is the reason peptides are so interesting to medicine. A well-designed peptide doesn't scatter its effects across your whole body. It targets the pathway it was designed for (Huberman, 2024).

When you hear about "growth hormone secretagogues" like sermorelin or ipamorelin, this is the mechanism: they bind to receptors in the pituitary gland and signal it to release growth hormone. They don't contain growth hormone. They tell your body to make more of its own.

That distinction is what separates growth hormone peptides from synthetic HGH, and it has significant implications for both safety and legality.

---

The Two Worlds of Peptide Therapy

This is the piece most articles skip, and it's the most important thing to understand before you make any decisions.

Not all peptides are created equal, and "peptide therapy" isn't one thing. It's two very different categories with completely different evidence bases, legal statuses, and safety profiles.

FDA-Approved Peptides

These are peptides that have gone through full clinical trials, received FDA approval, and are prescribed as conventional medications.

You likely know the biggest ones:

• Semaglutide (Ozempic, Wegovy, Rybelsus): FDA-approved for type 2 diabetes and chronic weight management. One of the most studied medications of the past decade.
• Liraglutide (Victoza, Saxenda): FDA-approved GLP-1 agonist for diabetes and weight loss.
• Bremelanotide (Vyleesi): FDA-approved for hypoactive sexual desire disorder in premenopausal women.
• Insulin: the original peptide drug, in use since 1922.
• Oxytocin: FDA-approved for labor induction and postpartum hemorrhage.
• Sermorelin: previously FDA-approved for growth hormone deficiency in children; now prescribed through 503A compounding pharmacies.

These peptides have documented human efficacy data, known side effect profiles, and physician prescribing protocols built on controlled trials. When someone loses 30+ pounds on semaglutide and it's covered (at least partially) by insurance, this is why: there's a large body of human clinical evidence supporting it.

Research Peptides

This is where it gets complicated.

Research peptides are compounds that have shown interesting results in animal studies and early laboratory research but have NOT completed the clinical trial process required for FDA drug approval. They're sometimes called "research chemicals." You'll see them sold online with labels saying "for research purposes only."

The most commonly discussed research peptides include:

• BPC-157: a synthetic peptide derived from a protein in gastric juice, studied for tissue repair and gut healing. Has not completed human clinical trials for any indication.
• Ipamorelin: a growth hormone releasing peptide (GHRP) studied for GH stimulation and recovery.
• CJC-1295: another GH secretagogue, often stacked with ipamorelin.
• TB-500 (Thymosin Beta-4 fragment): studied for wound healing and muscle repair in animal models.
• PT-141 (bremelanotide): the research version of what became FDA-approved Vyleesi.

The evidence gap here is real. Most research peptides have strong animal data. Human clinical trials are limited or nonexistent for therapeutic use. The FDA's adverse event database contains 152 adverse event reports linked to various peptide compounds (FDA FAERS, 2026). That's a signal worth taking seriously.

This doesn't mean research peptides are useless. It means you're working with less information, which requires physician oversight even more, not less.

---

Types of Peptides Used in Clinical Practice

Peptide therapy isn't a single drug. It's a category spanning several different therapeutic goals. Here's how physicians actually think about the major types (Gillette, 2025):

Growth Hormone Secretagogues

These peptides signal the pituitary gland to release growth hormone. The legitimate clinical use is treating adults with growth hormone insufficiency: low energy, poor body composition, disrupted sleep, and slow recovery that their doctor can't explain with standard labs.

Key compounds:

• Sermorelin: a GHRH analog. Previously FDA-approved for pediatric GHD, now widely prescribed through compounding pharmacies. Clinical evidence (Walker, 2006) suggests sermorelin is a well-tolerated option for adult-onset GH insufficiency with fewer risks than synthetic HGH.
• Ipamorelin: considered among the cleaner GHRPs because it stimulates GH release without significantly raising cortisol or prolactin.
• CJC-1295: a longer-acting GHRH analog, often combined with ipamorelin for more sustained GH pulses. The version without DAC is generally preferred by conservative physicians to avoid supraphysiologic GH levels.

If you want to understand more about how sermorelin works and what to expect, read our Sermorelin Before and After guide.

Healing and Recovery Peptides

BPC-157 is the most talked-about compound in this category. It's a 15-amino acid peptide found in small concentrations in gastric juice, synthesized for research purposes in its therapeutic form. Animal studies have shown effects on tissue repair, angiogenesis, nerve regeneration, and gut healing. The online community around BPC-157 is massive, and you'll find reports of people resolving tendon injuries, tennis elbow, and gut issues in weeks.

The catch: there are no completed human clinical trials for BPC-157 as a therapeutic drug. The data is preclinical. That's not a small distinction. Animal studies regularly show effects that don't translate to humans.

TB-500 (Thymosin Beta-4 fragment) operates similarly. Animal data on wound healing and muscle repair is present; human trial evidence is not.

Our full breakdown of BPC-157 Benefits covers the animal evidence in detail, including what it can and cannot tell us.

Metabolic Peptides (GLP-1 Agonists)

This is the category most people now know. GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking your body's natural GLP-1 hormone, which regulates blood sugar and appetite.

Semaglutide (Ozempic/Wegovy) became the breakout drug of the decade. In the STEP 1 trial (Wilding et al., 2021), participants lost an average of 14.9% of body weight over 68 weeks. At a starting weight of 200 pounds, that's about 30 pounds lost. The SUSTAIN trials established its cardiovascular safety profile and diabetes outcomes.

For a deeper look at how these work for weight loss specifically, see our guide to Peptides for Weight Loss.

Sexual Health Peptides

Bremelanotide (PT-141/Vyleesi) is the clearest example here. It started as a research peptide, went through clinical trials, and became an FDA-approved drug for hypoactive sexual desire disorder in premenopausal women. It works through melanocortin receptors in the brain, not through vascular mechanisms like PDE5 inhibitors.

Cosmetic Peptides

These are used topically in skincare: GHK-Cu (copper peptide), Matrixyl, Argireline, and others. They work at the skin level to stimulate collagen production, reduce inflammation, and support wound healing. No prescription required, lower risk profile, much less clinical controversy.

---

How Peptides Are Administered

The route of administration affects both how the peptide works and how it's regulated.

Injectable (subcutaneous): Most research and GH peptides are administered by injection into the subcutaneous fat layer under the skin, typically in the abdomen. This delivers the peptide directly into the bloodstream, bypassing the gut. Most growth hormone secretagogues and BPC-157 are administered this way.

Injectable (intramuscular): Some formulations are injected into muscle tissue for different absorption profiles.

Oral: Most peptides don't survive oral administration because your gut breaks amino acid chains into individual amino acids before they can be absorbed. Semaglutide is a notable exception. Its oral form (Rybelsus) uses a special absorption enhancer. Some peptides like BPC-157 are anecdotally reported to be somewhat active orally, but the bioavailability is lower than injectable forms.

Nasal: PT-141/bremelanotide was originally developed as a nasal spray before transitioning to injectable formulation.

Topical: Used primarily for cosmetic peptides and GHK-Cu. Does not produce systemic effects.

---

Regulatory Status: What's Legal and What Isn't

This matters. Before you consider any peptide, you need to understand where it sits legally.

FDA-approved peptides are conventional medications. You need a prescription, and they're dispensed through licensed pharmacies. Semaglutide, liraglutide, and bremelanotide all require prescriptions and are regulated like any other drug.

Sermorelin occupies a middle category: previously FDA-approved but now off the market as a branded drug. It's available through 503A compounding pharmacies with a physician's prescription. This is the legal pathway for many patients who want GH support without synthetic HGH.

Research peptides like BPC-157 are in contested territory. BPC-157 is classified as a bulk drug substance under FDA Category 2, meaning it's on the list for ongoing evaluation. The FDA has issued warning letters to compounders selling BPC-157 as a drug (FDA, 2025). In 2025-2026, there's active regulatory discussion (including interest from RFK Jr. in reclassifying certain peptides), but nothing has been formalized as of April 2026.

What this means practically: BPC-157 is not legal to sell as a drug for human therapeutic use in the US. Buying it from a compounding pharmacy or a "research chemical" website carries regulatory and quality risk. You have no guarantee of purity, concentration, or sterility from unregulated sources.

WADA and competitive athletes: If you compete in any sport governed by WADA or USADA, know this: BPC-157 is explicitly prohibited under the S0 (Non-Approved Substances) category (WADA, 2024). GH-releasing peptides including ipamorelin and CJC-1295 are prohibited under S2 (Peptide Hormones, Growth Factors). A positive test is a positive test regardless of whether you have a prescription. The USADA has published specific athlete advisories on BPC-157 as a prohibited substance (USADA, 2023).

---

Are Peptides Safe?

The honest answer: it depends entirely on which peptide, the source, the dose, and whether you have physician oversight.

FDA-approved peptides have established safety profiles from large clinical trials. Semaglutide's side effects (nausea, GI upset, the rare risk of pancreatitis) are well-documented and physicians know how to manage them (Wilding et al., 2021). Bremelanotide (Vyleesi) has a known side effect profile including temporary increases in blood pressure (FDA, 2019).

Research peptides are a different story. The safety data is primarily from animal studies. The FDA's FAERS database has 152 adverse event reports linked to peptide compounds. These range from injection site reactions to systemic effects, but tracking is incomplete because research peptides often aren't reported under their own names.

Quality is the variable most people underestimate. A peptide bought from an overseas supplier or an unregulated US vendor might be:

• Dosed incorrectly (mislabeled concentration)
• Contaminated with bacterial endotoxins
• A completely different compound than labeled
• Not sterile

Injection site abscesses, systemic infections, and hormonal disruption have all been reported with unverified peptide sources. None of that happens when you're working with a licensed compounding pharmacy operating under USP standards.

The legitimacy question is simple: Is a licensed physician reviewing your labs, assessing your history, and prescribing through a licensed pharmacy? If yes, the risk profile is manageable. If not, you're improvising with your endocrine system.

---

What Does Peptide Therapy Actually Cost?

Let's be direct, because nobody else is.

FDA-approved peptides:

• Semaglutide (Ozempic): $800-$1,000+/month without insurance. With insurance for qualifying Type 2 diabetes: often covered. Wegovy (weight management indication): insurance coverage improving but still inconsistent.
• Bremelanotide (Vyleesi): $800-$900/month. Insurance coverage limited.

Research/compounding peptides (cash-pay only):

• Sermorelin: typically $50-$400/month through compounding pharmacies
• BPC-157: $100-$300/cycle from compounding sources (where legally available)
• Ipamorelin/CJC-1295 combination: $200-$500/month

Lab work: Initial labs to evaluate hormone levels, IGF-1, metabolic panel: typically $200-$500.

The catch: research peptides are not covered by insurance under any circumstances. You're paying cash. That's worth knowing before you plan a protocol.

At HEXIS, we work with patients to evaluate whether the evidence supports their goals, what's legally prescribable, and what the cost looks like for their specific situation. Your protocol starts with labs, not guesswork.

---

How to Access Peptide Therapy Legitimately

The market for peptides is full of gray-area vendors. Here's how to tell the difference between a legitimate peptide clinic and a gray-market operation.

A legitimate clinic:

• Requires lab work before prescribing (IGF-1, hormone panel, metabolic panel minimum)
• Works with licensed 503A compounding pharmacies (sterile, US-regulated)
• Has licensed physicians reviewing your case and signing off on any prescription
• Only prescribes compounds that have a legal pathway for human use
• Offers ongoing monitoring as part of the protocol

A gray-market vendor:

• Sells "for research purposes only" with no medical involvement
• No labs required
• No physician oversight
• Products shipped from overseas with no quality verification

The compounding pharmacy pathway exists specifically to give patients access to physician-prescribed peptides that aren't available as commercial drugs. Sermorelin compounded through a 503A pharmacy is legal, regulated, and quality-controlled. BPC-157 through the same pathway exists in a grayer zone, as FDA guidance as of 2026 is still evolving.

If you want to explore peptide therapy, HEXIS connects you with licensed physicians who understand the compounds, will evaluate your labs, and will only prescribe within the legal framework. We don't do gray market. Schedule a consultation and we'll start with your bloodwork.

---

Frequently Asked Questions About Peptides

What are peptides and how are they different from proteins?

Peptides are short chains of amino acids, typically 2 to 50 units long. Proteins are longer, more structurally complex chains of amino acids, often hundreds or thousands of units long. Your body produces tens of thousands of peptides naturally; they act as messengers, hormones, and regulators. The shorter length makes peptides faster to synthesize and more targeted in their biological effects than most proteins.

Are peptides the same as steroids?

No. Steroids are lipid-based (fat-soluble) compounds that work through different receptor mechanisms and affect gene expression. Peptides are amino acid chains that work through cell-surface receptors. The physiological effects can overlap in some areas (both can influence body composition, for example), but the mechanisms, legal status, and risk profiles are different. Semaglutide, sermorelin, and BPC-157 are peptides. Testosterone, anavar, and prednisone are steroids.

What is the difference between FDA-approved peptides and research peptides?

FDA-approved peptides have completed clinical trials demonstrating safety and efficacy in humans for a specific indication. They're prescribed as medications. Research peptides have animal data and preliminary research but have not completed the human trial process for therapeutic use. They exist in a regulatory gray zone: not approved for human use, not always illegal to possess, but not legal to sell as drugs. The evidence gap between these categories is significant.

Will peptides show up on a drug test?

It depends on the test and the peptide. Growth hormone releasing peptides (ipamorelin, CJC-1295, sermorelin) and BPC-157 are all prohibited by WADA and USADA, and can be detected on sports drug tests. GLP-1 peptides like semaglutide are not typically on standard employment drug screens. If you're a competitive athlete subject to WADA testing, assume any peptide therapy beyond FDA-approved medications requires careful review. Some are explicitly prohibited, and there are no therapeutic use exemptions for most research peptides.

How do I know if a peptide clinic is legitimate?

A legitimate clinic requires bloodwork before prescribing, works with licensed US compounding pharmacies, has physicians reviewing each case, and only prescribes compounds with a legal pathway for human therapeutic use. Red flags include no lab requirement, no physician involvement, overseas pharmacy sourcing, or "for research purposes only" language without any medical oversight structure.

---

Starting with What Are Peptides: What Comes Next

Peptides are a broad category that includes some of the most effective medications ever developed and some of the most speculative compounds in the wellness space. The difference matters.

If you're researching peptides because you're dealing with slow recovery, low energy, poor sleep, or weight that won't move despite real effort, that's worth a proper evaluation. Not a Reddit protocol and a gray-market vial. A physician who can look at your labs, understand your goals, and tell you what actually makes sense for your situation.

What are peptides going to do for you? That depends on which one, why you're using it, and whether you have the oversight to use it correctly. That's what a HEXIS consultation answers.

Schedule a consultation. Your protocol starts with labs, not guesswork.

---